首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.
【24h】

Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.

机译:健康志愿者中厄贝沙坦(一种血管紧张素拮抗剂)的口服生物利用度和处置特性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Absolute oral bioavailability and disposition characteristics of irbesartan, an angiotensin II receptor antagonist, were investigated in 18 healthy young male volunteers. Subjects received [14C] irbesartan as a 30-minute intravenous infusion (50 mg), [14C] irbesartan orally as a solution (50 mg or 150 mg), or irbesartan capsule (50 mg). Irbesartan was rapidly and almost completely absorbed after oral administration, and exhibited a mean absolute oral bioavailability of 60% to 80%. Mean total body clearance was approximately 157 mL/min, and renal clearance was 3.0 mL/min. Volume of distribution at steady state was 53 L to 93 L, and terminal elimination half-life was approximately 13 to 16 hours. Hepatic extraction ratio was low (0.2). There were no major circulating metabolites, and approximately 80% of total plasma radioactivity was attributable to unchanged irbesartan. Regardless of route of administration, approximately 20% of dose was recovered in urine and the remainder in feces.
机译:在18位健康的年轻男性志愿者中研究了厄贝沙坦(一种血管紧张素II受体拮抗剂)的绝对口服生物利用度和处置特性。受试者接受[14C]厄贝沙坦静脉输注30分钟(50 mg),[14C]厄贝沙坦口服溶液(50 mg或150 mg)或厄贝沙坦胶囊(50 mg)。厄贝沙坦口服后迅速,几乎完全吸收,平均口服绝对生物利用度为60%至80%。平均全身清除率约为157 mL / min,而肾脏清除率则为3.0 mL / min。稳定状态下的分配量为53 L至93 L,最终消除半衰期约为13至16小时。肝提取率低(0.2)。没有主要的循环代谢产物,约80%的总血浆放射性可归因于厄贝沙坦的不变。不论给药途径如何,大约20%的剂量可从尿液中回收,其余的可在粪便中回收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号